AT375931B - Verfahren zur herstellung von neuen aminoalkylfuranderivaten - Google Patents

Verfahren zur herstellung von neuen aminoalkylfuranderivaten

Info

Publication number
AT375931B
AT375931B AT0574077A AT574077A AT375931B AT 375931 B AT375931 B AT 375931B AT 0574077 A AT0574077 A AT 0574077A AT 574077 A AT574077 A AT 574077A AT 375931 B AT375931 B AT 375931B
Authority
AT
Austria
Prior art keywords
aminoalkylfuranderivatives
producing new
producing
new
new aminoalkylfuranderivatives
Prior art date
Application number
AT0574077A
Other languages
German (de)
English (en)
Other versions
ATA574077A (de
Inventor
Barry John Price
John Watson Clitherow
John Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT375931(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Priority to AT0322880A priority Critical patent/AT381937B/de
Publication of ATA574077A publication Critical patent/ATA574077A/de
Application granted granted Critical
Publication of AT375931B publication Critical patent/AT375931B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT0574077A 1976-08-04 1977-08-04 Verfahren zur herstellung von neuen aminoalkylfuranderivaten AT375931B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0322880A AT381937B (de) 1976-08-04 1980-06-18 Verfahren zur herstellung von neuen aminoalkylfuranderivaten sowie deren tautomeren, diastereoisomeren bzw. optischen enantiomeren

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (2)

Publication Number Publication Date
ATA574077A ATA574077A (de) 1984-02-15
AT375931B true AT375931B (de) 1984-09-25

Family

ID=27448487

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0574077A AT375931B (de) 1976-08-04 1977-08-04 Verfahren zur herstellung von neuen aminoalkylfuranderivaten

Country Status (16)

Country Link
AT (1) AT375931B (xx)
CH (2) CH642072A5 (xx)
CY (1) CY1077A (xx)
DE (2) DE2759959C2 (xx)
DK (2) DK148258C (xx)
ES (2) ES461334A1 (xx)
FI (1) FI72318C (xx)
HK (1) HK55780A (xx)
IE (1) IE45456B1 (xx)
IT (2) IT1126759B (xx)
KE (1) KE3080A (xx)
NZ (2) NZ191383A (xx)
PH (1) PH13540A (xx)
PT (1) PT66874B (xx)
SE (3) SE437373B (xx)
YU (2) YU40006B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Also Published As

Publication number Publication date
HK55780A (en) 1980-10-10
DK337977A (da) 1978-02-05
SE8206556L (sv) 1982-11-17
CH642072A5 (en) 1984-03-30
CY1077A (en) 1980-12-27
IT1126759B (it) 1986-05-21
DK149952C (da) 1987-07-06
DE2759959C2 (xx) 1988-08-04
KE3080A (en) 1980-10-03
DK416384D0 (da) 1984-08-30
IT1221058B (it) 1990-06-21
SE7708521L (sv) 1978-02-05
SE454882B (sv) 1988-06-06
SE8205533L (sv) 1982-09-28
SE437373B (sv) 1985-02-25
IE45456B1 (en) 1982-08-25
IT8548437A0 (it) 1985-08-01
YU40088B (en) 1985-06-30
SE8205533D0 (sv) 1982-09-28
SE454883B (sv) 1988-06-06
PH13540A (en) 1980-06-26
FI772264A (xx) 1978-02-05
DK148258B (da) 1985-05-20
FI72318B (fi) 1987-01-30
DE2760097C2 (xx) 1989-08-17
FI72318C (fi) 1987-05-11
PT66874B (en) 1979-01-23
ES461334A1 (es) 1979-05-16
YU200082A (en) 1983-01-21
NZ191383A (en) 1980-09-12
DK416384A (da) 1984-08-30
IE45456L (en) 1978-02-04
ES470836A1 (es) 1979-02-16
SE8206556D0 (sv) 1982-11-17
YU191177A (en) 1983-01-21
DK149952B (da) 1986-11-03
YU40006B (en) 1985-06-30
ATA574077A (de) 1984-02-15
PT66874A (en) 1977-09-01
DK148258C (da) 1985-10-14
CH641176A5 (en) 1984-02-15
NZ184759A (en) 1980-09-12

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT355571B (de) Verfahren zur herstellung von neuen bis -pyridinium-verbindungen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT361638B (de) Verfahren zur herstellung von neuen dimeren indoldihydroindoldionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT360647B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT351515B (de) Verfahren zur herstellung von neuen polyenver- bindungen
AT364367B (de) Verfahren zur herstellung von neuen oxepinen
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen
ATA570179A (de) Verfahren zur herstellung von neuen d-homosteroiden

Legal Events

Date Code Title Description
ELA Expired due to lapse of time